For pharmaceutical companies, nothing is more fundamental to business success than bringing drugs and medical devices to market rapidly and efficiently. Clinical trials are critical to that success as they provide the basis for submission, approval, labeling and marketing of a compound or device. Without well-organized, easily accessible, thoroughly-documented data from well-designed trials, the value of a drug or device may not be fully realized.
Even as pharmaceutical companies continue to increasingly transfer any or all of their trial-related duties to contract research organization’s (CROs), the quality and integrity of trial data continue to reside with the pharmaceutical company. But for CROs to remain competitive in the marketplace, they are realizing the importance of implementing quality assurance and quality controls over data to support their sponsor’s trial requirements.
CROs are quickly beginning to understand that pharmaceutical sponsors are not in the business, nor wish to be in the business, of running clinical trials. Their sponsor’s business of manufacturing new medications provides CROs the opportunity to grow and expand their presence in the CRO market-space. But to remain competitive, CROs are also assuming the additional expense of maintaining personnel, ensuring staff expertise, and acquiring the IT infrastructure costs required to handle an influx of data from new clinical trial contracts.
But as trials are increasingly outsourced to contract research organizations (CROs), the ability to integrate and exchange data seamlessly has proven to be challenging for both sponsor companies and their CRO partners.
To learn how your organization can implement a unique solution that leverages cloud-based technology to address these industry challenges, download our latest white paper now!